crc press - E-Lib FK UWKS

Quantification of Cell-Penetrating Peptides and Their Cargoes 275
11. Fischer, P.M. et al., Structure-activity relationship of truncated and substituted analogues
of the intracellular delivery vector penetratin, J. Pept. Res., 55, 163–172, 2000.
12. Meldal, M. and Breddam, K., Anthranilamide and nitrotyrosine as a donor-acceptor
pair in internally quenched fluorescent substrates for endopeptidases: multicolumn
peptide synthesis of enzyme substrates for subtilisin Carlsberg and pepsin, Anal.
Biochem., 195, 141–147, 1991.
13. Wang, Y.L., Fluorescent analog cytochemistry: tracing functional protein components
in living cells, Methods Cell Biol., 29, 1–12, 1989.
14. Garcia–Echeverria, C. et al., A new Antennapedia-derived vector for intracellular
delivery of exogenous compounds, Bioorg. Med. Chem. Lett., 11, 1363–1366, 2001.
15. Scheller, A. et al., Structural requirements for cellular uptake of alpha-helical amphipathic
peptides, J. Pept. Sci., 5, 185–194, 1999.
16. Gazit, E. and Shai, Y., The assembly and organization of the alpha 5 and alpha 7
helices from the pore-forming domain of Bacillus thuringiensis delta-endotoxin.
Relevance to a functional model, J. Biol. Chem., 270, 2571–2578, 1995.
17. Elmquist, A. et al., VE-Cadherin-Derived Cell-Penetrating Peptide, pVEC, with carrier
functions, Exp. Cell Res., 269, 237–244, 2001.
18. Vives, E., Brodin, P., and Lebleu, B., A truncated HIV-1 Tat protein basic domain
rapidly translocates through the plasma membrane and accumulates in the cell
nucleus, J. Biol. Chem., 272, 16010–16017, 1997.
19. Matayoshi, E.D. et al., Novel fluorogenic substrates for assaying retroviral proteases
by resonance energy transfer, Science, 247, 954–958, 1990.
20. Kuzmic, P., Program DYNAFIT for the analysis of enzyme kinetic data: application
to HIV proteinase, Anal. Biochem., 237, 260–273, 1996.
21. Rojas, M. et al., An alternative to phosphotyrosine-containing motifs for binding to
an SH2 domain, Biochem. Biophys. Res. Commun., 234, 675–680, 1997.
22. Dunican, D.J. and Doherty, P., Designing cell-permeant phosphopeptides to modulate
intracellular signaling pathways, Biopolymers, 60, 45–60, 2001.
23. Herbert, T.P. et al., Rapid induction of apoptosis mediated by peptides that bind
initiation factor eIF4E, Curr. Biol., 10, 793–796, 2000.
24. Chaloin, L. et al., Design of carrier peptide-oligonucleotide conjugates with rapid
membrane translocation and nuclear localization properties, Biochem. Biophys. Res.
Commun., 243, 601–608, 1998.
25. Pooga, M. et al., Cell penetrating PNA constructs regulate galanin receptor levels and
modify pain transmission in vivo, Nat. Biotechnol., 16, 857–8561, 1998.
26. Rousselle, C. et al., New advances in the transport of doxorubicin through the
blood–brain barrier by a peptide vector-mediated strategy, Mol. Pharmacol., 57,
679–686, 2000.
27. Mazel, M. et al., Doxorubicin–peptide conjugates overcome multidrug resistance,
Anticancer Drugs, 12, 107–116, 2001.
28. Allinquant, B. et al., Downregulation of amyloid precursor protein inhibits neurite
outgrowth in vitro, J. Cell Biol., 128, 919–927, 1995.
29. Rousselle, C. et al., Enhanced delivery of doxorubicin into the brain via a peptidevector-mediated
strategy: saturation kinetics and specificity, J Pharmacol. Exp. Ther.,
296, 124–131, 2001.